Spoiler alert: Your pennies may not be worth much more than the aforementioned freebies. That is, of course, dependent on a ...

In a bid to get it above the NASDAQ-required minimum, Polestar ($PSNY) is rumored to be considering a 1:30 reverse stock ...

The Boston Police Department is warning shoppers to be cautious of scams as we enter the holiday season.Three common scams ...

While there is plenty of criticism to be hurled at what music the algorithm serves to us, and how, the real problem with music discovery in the age of algorithmic recommendations is that listening has ...

If typing search operators feels like too much work, you don’t have to memorize them. Just click the sliders icon at the far ...

The senators’ comments came after House Speaker Mike Johnson said he would hold a vote on the House floor to repeal the ...

The AI Window feature will serve 'as a trusted companion, enhancing your browsing experience and guiding you outward to the ...

Jodi: That was Helen Davies, SVP Head of Talent at TD Bank. The New Work is produced by the HRPA and the Globe Content Studio ...

Believe it -- this year can be your year for finally landing a remote job! Or, if you're lucky, maybe you can land something ...

A rally in the Colombian peso is going into reverse on speculation that the government’s rush of dollar sales, which pushed the currency to a three-year high earlier this week, is coming to an end.

Experts say we’re in a golden age for treating chronic kidney disease, with new drugs like Ozempic yielding major results.

Living to 150 is not science fiction according to chief technology officer Lyu Qinghua of Lonvi Biosciences, one of many Chinese companies working on anti-ageing treatments.